Pancreatic neuroendocrine neoplasms: Updates on genomic changes in inherited tumour syndromes and sporadic tumours based on WHO classification
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pancreatic neuroendocrine neoplasms: Updates on genomic changes in inherited tumour syndromes and sporadic tumours based on WHO classification
Authors
Keywords
Pancreas, Pancreatic neuroendocrine neoplasm, Pancreatic neuroendocrine tumour, Pancreatic neuroendocrine carcinoma, Inherited tumour syndrome, Genetics, MicroRNAs, Immune microenvironment
Journal
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Volume 172, Issue -, Pages 103648
Publisher
Elsevier BV
Online
2022-03-04
DOI
10.1016/j.critrevonc.2022.103648
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adult Proinsulinomatosis Associated With a MAFA Germline Mutation as a Rare Cause of Recurrent Hypoglycemia
- (2022) Ioannis Mintziras et al. PANCREAS
- Lenvatinib in Patients With Advanced Grade 1/2 Pancreatic and Gastrointestinal Neuroendocrine Tumors: Results of the Phase II TALENT Trial (GETNE1509)
- (2021) Jaume Capdevila et al. JOURNAL OF CLINICAL ONCOLOGY
- Sex-biased islet β cell dysfunction is caused by the MODY MAFA S64F variant by inducing premature aging and senescence in males
- (2021) Emily M. Walker et al. Cell Reports
- miR-431 Promotes Metastasis of Pancreatic Neuroendocrine Tumors by Targeting DAB2 Interacting Protein, a Ras GTPase Activating Protein Tumor Suppressor
- (2020) Tiantian Zhang et al. AMERICAN JOURNAL OF PATHOLOGY
- Gallbladder Mixed Neuroendocrine-Non-neuroendocrine Neoplasm (MiNEN) Arising in Intracholecystic Papillary Neoplasm: Clinicopathologic and Molecular Analysis of a Case and Review of the Literature
- (2020) Amedeo Sciarra et al. ENDOCRINE PATHOLOGY
- Alternative Lengthening of Telomeres and Differential Expression of Endocrine Transcription Factors Distinguish Metastatic and Non-metastatic Insulinomas
- (2020) Wenzel M. Hackeng et al. ENDOCRINE PATHOLOGY
- Revised Danish guidelines for the cancer surveillance of patients with Cowden Syndrome
- (2020) Maja Patricia Smerdel et al. European Journal of Medical Genetics
- Co-occurrence of multiple endocrine neoplasia type 4 and spinal neurofibromatosis: a case report
- (2020) Pamela Brock et al. Familial Cancer
- Mixed Neuroendocrine Non-Neuroendocrine Neoplasms: A Systematic Review of a Controversial and Underestimated Diagnosis
- (2020) Melissa Frizziero et al. Journal of Clinical Medicine
- Pancreatic neuroendocrine tumors: A review of serum biomarkers, staging, and management
- (2020) Zu-Yi Ma et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Immune checkpoint pathways in immunotherapy for head and neck squamous cell carcinoma
- (2020) Zi Mei et al. International Journal of Oral Science
- Multiple Endocrine Neoplasia Type 4: Novel CDNK1B variant and immune anomalies
- (2020) B. Chevalier et al. ANNALES D ENDOCRINOLOGIE
- Prognostic factors for the outcome of nonfunctioning pancreatic neuroendocrine tumors in MEN1: a systematic review of literature
- (2020) S M Sadowski et al. ENDOCRINE-RELATED CANCER
- p53-PHLDA3-Akt Network: The Key Regulators of Neuroendocrine Tumorigenesis
- (2020) Yu Chen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Malignant Insulinoma Is Largely Derived From Nonfunctioning Pancreatic Neuroendocrine Tumors
- (2020) Run Yu PANCREAS
- Surufatinib in advanced pancreatic neuroendocrine tumours (SANET-p): a randomised, double-blind, placebo-controlled, phase 3 study
- (2020) Jianming Xu et al. LANCET ONCOLOGY
- Genomic profiling of NETs: a comprehensive analysis of the RADIANT trials
- (2019) James C Yao et al. ENDOCRINE-RELATED CANCER
- Gastroenteropancreatic neuroendocrine tumors in Iceland: a population-based study
- (2019) Hallbera Gudmundsdottir et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Patient characteristics and clinical outcomes following initial surgical intervention for MEN1 associated pancreatic neuroendocrine tumours: A systematic review and exploratory meta-analysis of the literature
- (2019) Chathura Bathiya Bandara Ratnayake et al. PANCREATOLOGY
- Immune checkpoint markers in gastroenteropancreatic neuroendocrine neoplasia
- (2019) Florian Bösch et al. ENDOCRINE-RELATED CANCER
- MiRNA-3653 Is a Potential Tissue Biomarker for Increased Metastatic Risk in Pancreatic Neuroendocrine Tumours
- (2019) Preetjote Gill et al. ENDOCRINE PATHOLOGY
- Clinical Features of Multiple Endocrine Neoplasia Type 4 - Novel pathogenic variant and review of published cases
- (2019) Anja Frederiksen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Clinical analysis of 547 patients with neuroendocrine tumors in a Chinese population: A single‐center study
- (2019) Lijie Song et al. Cancer Medicine
- Rare BRAF mutations in pancreatic neuroendocrine tumors may predict response to RAF and MEK inhibition
- (2019) Amy Allen et al. PLoS One
- The evolving (epi)genetic landscape of pancreatic neuroendocrine tumours
- (2019) Christodoulos P Pipinikas et al. ENDOCRINE-RELATED CANCER
- Whole-genome sequencing reveals distinct genetic bases for insulinomas and non-functional pancreatic neuroendocrine tumours: leading to a new classification system
- (2019) Xiafei Hong et al. GUT
- Neuroendocrine neoplasms of the small bowel and pancreas
- (2019) Ashley Kieran Clift et al. NEUROENDOCRINOLOGY
- Immunohistochemically Detected Expression of ATRX, TSC2, and PTEN Predicts Clinical Outcomes in Patients With Grade 1 and 2 Pancreatic Neuroendocrine Tumors
- (2019) Jun Uemura et al. ANNALS OF SURGERY
- Exploring the current status of neuroendocrine tumours: a population-based analysis of epidemiology, management and use of resources
- (2019) Josep Darbà et al. BMC CANCER
- Epidemiological trends of neuroendocrine tumours over three decades in Queensland, Australia
- (2019) David Wyld et al. Cancer Epidemiology
- DAXX mutations as potential genomic markers of malignant evolution in small nonfunctioning pancreatic neuroendocrine tumors
- (2019) Mauro Cives et al. Scientific Reports
- Neoplasms of the Neuroendocrine Pancreas
- (2018) Julie M. Guilmette et al. ADVANCES IN ANATOMIC PATHOLOGY
- Preventive medicine of von Hippel–Lindau disease-associated pancreatic neuroendocrine tumors
- (2018) Tobias Krauss et al. ENDOCRINE-RELATED CANCER
- Evaluating gastroenteropancreatic neuroendocrine tumors through microRNA sequencing
- (2018) Nicole Panarelli et al. ENDOCRINE-RELATED CANCER
- Prognostic relevance of proliferation-related miRNAs in pancreatic neuroendocrine neoplasms
- (2018) Vince Kornél Grolmusz et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Pancreatic neuroendocrine carcinomas reveal a closer relationship to ductal adenocarcinomas than to neuroendocrine tumors G3
- (2018) Björn Konukiewitz et al. HUMAN PATHOLOGY
- Genomic landscape of pancreatic neuroendocrine tumours: the International Cancer Genome Consortium
- (2018) Andrea Mafficini et al. JOURNAL OF ENDOCRINOLOGY
- A Comprehensive Assessment of the Role of miRNAs as Biomarkers in Gastroenteropancreatic Neuroendocrine Tumors
- (2018) Anna Malczewska et al. NEUROENDOCRINOLOGY
- MAFAmissense mutation causes familial insulinomatosis and diabetes mellitus
- (2018) Donato Iacovazzo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- c-MYC amplification and c-myc protein expression in pancreatic acinar cell carcinomas. New insights into the molecular signature of these rare cancers
- (2018) Stefano La Rosa et al. VIRCHOWS ARCHIV
- Molecular Genetic Studies of Pancreatic Neuroendocrine Tumors
- (2018) Mark Stevenson et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- ATRX loss is an independent predictor of poor survival in pancreatic neuroendocrine tumours
- (2018) Angela Chou et al. HUMAN PATHOLOGY
- Characterization of the Neuroendocrine Tumor Immune Microenvironment
- (2018) Annacarolina da Silva et al. PANCREAS
- Chemotherapeutic Treatments Increase PD-L1 Expression in Esophageal Squamous Cell Carcinoma through EGFR/ERK Activation
- (2018) Hoi Yan Ng et al. Translational Oncology
- Profiling the Tumour Immune Microenvironment in Pancreatic Neuroendocrine Neoplasms with Multispectral Imaging Indicates Distinct Subpopulation Characteristics Concordant with WHO 2017 Classification
- (2018) Daigoro Takahashi et al. Scientific Reports
- Genetic Analysis of Small Well-differentiated Pancreatic Neuroendocrine Tumors Identifies Subgroups With Differing Risks of Liver Metastases
- (2018) Antonio Pea et al. ANNALS OF SURGERY
- Gastroenteropancreatic Neuroendocrine Tumors
- (2018) Mauro Cives et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Advances in the cytologic diagnosis of gastroenteropancreatic neuroendocrine neoplasms
- (2018) Carlie S. Sigel CANCER CYTOPATHOLOGY
- Incidence Trends of Gastroenteropancreatic Neuroendocrine Tumors in the United States
- (2018) Mi Ri Lee et al. Clinical Gastroenterology and Hepatology
- The Molecular and Clinical Landscape of Pancreatic Neuroendocrine Tumors
- (2018) Bhavina D.O. Batukbhai et al. PANCREAS
- Analysis of expression of the PD-1/PD-L1 immune checkpoint system and its prognostic impact in gastroenteropancreatic neuroendocrine tumors
- (2018) Miguel Sampedro-Núñez et al. Scientific Reports
- Prognosis of patients with neuroendocrine tumor: a SEER database analysis
- (2018) Da Man et al. Cancer Management and Research
- MEN4 and CDKN1B mutations: the latest of the MEN syndromes
- (2017) Rami Alrezk et al. ENDOCRINE-RELATED CANCER
- Pancreatic Neuroendocrine Neoplasms: Basic Biology, Current Treatment Strategies and Prospects for the Future
- (2017) Akihiro Ohmoto et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Combination of dabrafenib plus trametinib for BRAF and MEK inhibitor pretreated patients with advanced BRAF V600 -mutant melanoma: an open-label, single arm, dual-centre, phase 2 clinical trial
- (2017) Max Schreuer et al. LANCET ONCOLOGY
- SOX2 and Rb1 in esophageal small-cell carcinoma: their possible involvement in pathogenesis
- (2017) Hirotaka Ishida et al. MODERN PATHOLOGY
- Whole-genome landscape of pancreatic neuroendocrine tumours
- (2017) Aldo Scarpa et al. NATURE
- Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
- (2017) Jonathan Strosberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase II Study of BEZ235 versus Everolimus in Patients with Mammalian Target of Rapamycin Inhibitor‐Naïve Advanced Pancreatic Neuroendocrine Tumors
- (2017) Ramon Salazar et al. ONCOLOGIST
- Role of PD-L1 expression as a biomarker for GEP neuroendocrine neoplasm grading
- (2017) Elisabetta Cavalcanti et al. Cell Death & Disease
- Significance of PI3K/AKT signaling pathway in metastasis of esophageal squamous cell carcinoma and its potential as a target for anti-metastasis therapy
- (2017) Bin Li et al. Oncotarget
- A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas
- (2016) Laura H. Tang et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Sunitinib in Pancreatic Neuroendocrine Tumors: Updated Progression-Free Survival and Final Overall Survival From a Phase III Randomized Study
- (2016) S. Faivre et al. ANNALS OF ONCOLOGY
- Modulatory roles of microRNAs in the regulation of different signalling pathways in large bowel cancer stem cells
- (2016) Afraa Mamoori et al. BIOLOGY OF THE CELL
- Molecular profiling of neuroendocrine malignancies to identify prognostic and therapeutic markers: a Fox Chase Cancer Center Pilot Study
- (2016) Namrata Vijayvergia et al. BRITISH JOURNAL OF CANCER
- Alternative Lengthening of Telomeres and Loss of DAXX/ATRX Expression Predicts Metastatic Disease and Poor Survival in Patients with Pancreatic Neuroendocrine Tumors
- (2016) Aatur D. Singhi et al. CLINICAL CANCER RESEARCH
- The biological effects and clinical implications of BRCA mutations: where do we go from here?
- (2016) Dominique Stoppa-Lyonnet EUROPEAN JOURNAL OF HUMAN GENETICS
- Neuroendocrine Tumor of the Pancreas as a Manifestation of Cowden Syndrome: A Case Report
- (2016) V. Neychev et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Genomic analyses identify molecular subtypes of pancreatic cancer
- (2016) Peter Bailey et al. NATURE
- ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site
- (2016) M. Pavel et al. NEUROENDOCRINOLOGY
- Pancreatic tumors in children and young adults with tuberous sclerosis complex
- (2016) Gonca Koc et al. PEDIATRIC RADIOLOGY
- The Impact of PD-L1 Expression in Patients with Metastatic GEP-NETs
- (2016) Seung Tae Kim et al. Journal of Cancer
- Notch Signaling in Neuroendocrine Tumors
- (2016) Judy S. Crabtree et al. Frontiers in Oncology
- Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine Carcinomas
- (2015) L. H. Tang et al. CLINICAL CANCER RESEARCH
- Characteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms
- (2015) M Heetfeld et al. ENDOCRINE-RELATED CANCER
- miR-144/451 Promote Cell Proliferation via Targeting PTEN/AKT Pathway in Insulinomas
- (2015) Xiuli Jiang et al. ENDOCRINOLOGY
- Clinical pathological impacts of microRNAs in papillary thyroid carcinoma: A crucial review
- (2015) Anna Chruścik et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Glucagon Cell Hyperplasia and Neoplasia With and Without Glucagon Receptor Mutations
- (2015) Bence Sipos et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Multicenter Phase II Trial of Temsirolimus and Bevacizumab in Pancreatic Neuroendocrine Tumors
- (2015) Timothy J. Hobday et al. JOURNAL OF CLINICAL ONCOLOGY
- Pazopanib and depot octreotide in advanced, well-differentiated neuroendocrine tumours: a multicentre, single-group, phase 2 study
- (2015) Alexandria T Phan et al. LANCET ONCOLOGY
- Comprehensive genomic profiles of small cell lung cancer
- (2015) Julie George et al. NATURE
- A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic Characteristics
- (2015) A. Sadanandam et al. Cancer Discovery
- Comprehensive cancer-gene panels can be used to estimate mutational load and predict clinical benefit to PD-1 blockade in clinical practice
- (2015) Luís Felipe Campesato et al. Oncotarget
- Genetics of pancreatic neuroendocrine tumors: implications for the clinic
- (2015) Antonio Pea et al. Expert Review of Gastroenterology & Hepatology
- Mosaic and Intronic Mutations in TSC1/TSC2 Explain the Majority of TSC Patients with No Mutation Identified by Conventional Testing
- (2015) Magdalena E. Tyburczy et al. PLoS Genetics
- The Important Roles of miR-205 in Normal Physiology, Cancers and as a Potential Therapeutic Target
- (2014) Haleh Vosgha et al. CURRENT CANCER DRUG TARGETS
- Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis
- (2014) C R C Pieterman et al. ENDOCRINE-RELATED CANCER
- Does the WHO 2010 classification of pancreatic neuroendocrine neoplasms accurately characterize pancreatic neuroendocrine carcinomas?
- (2014) Susumu Hijioka et al. JOURNAL OF GASTROENTEROLOGY
- Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis
- (2014) Tetsuhide Ito et al. JOURNAL OF GASTROENTEROLOGY
- Clinical Application of MicroRNA Testing in Neuroendocrine Tumors of the Gastrointestinal Tract
- (2014) Caterina Vicentini et al. MOLECULES
- Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors
- (2014) Martyn E. Caplin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telomerase Inhibitor Imetelstat (GRN163L) Limits the Lifespan of Human Pancreatic Cancer Cells
- (2014) Katrina M. Burchett et al. PLoS One
- PHLDA3 is a novel tumor suppressor of pancreatic neuroendocrine tumors
- (2014) R. Ohki et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNA Array Analysis Finds Elevated Serum miR-1290 Accurately Distinguishes Patients with Low-Stage Pancreatic Cancer from Healthy and Disease Controls
- (2013) A. Li et al. CLINICAL CANCER RESEARCH
- Loss of DAXX and ATRX Are Associated With Chromosome Instability and Reduced Survival of Patients With Pancreatic Neuroendocrine Tumors
- (2013) Ilaria Marinoni et al. GASTROENTEROLOGY
- Atrx deficiency induces telomere dysfunction, endocrine defects, and reduced life span
- (2013) L. Ashley Watson et al. JOURNAL OF CLINICAL INVESTIGATION
- High cumulative risks of cancer in patients withPTENhamartoma tumour syndrome
- (2013) Virginie Bubien et al. JOURNAL OF MEDICAL GENETICS
- Causes of Death and Prognostic Factors in Multiple Endocrine Neoplasia Type 1
- (2013) Tetsuhide Ito et al. MEDICINE
- Role of MUTYH in human cancer
- (2013) Filomena Mazzei et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Glucagon Cell Adenomatosis Without Glucagon Receptor Mutation
- (2013) Bilal Al-Sarireh et al. PANCREAS
- Clinicopathological relevance of BRAF mutations in human cancer
- (2013) Sahar Pakneshan et al. PATHOLOGY
- Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway
- (2013) Jiri Polivka et al. PHARMACOLOGY & THERAPEUTICS
- Small Cell and Large Cell Neuroendocrine Carcinomas of the Pancreas are Genetically Similar and Distinct From Well-differentiated Pancreatic Neuroendocrine Tumors
- (2012) Shinichi Yachida et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Estimate of de novo mutation frequency in probands with PTEN hamartoma tumor syndrome
- (2012) Jessica Mester et al. GENETICS IN MEDICINE
- The Current Strategy for Managing Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1
- (2012) Yusuke Niina et al. Gut and Liver
- Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
- (2012) Rajesh V. Thakker et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Molecular pathology and genetics of pancreatic endocrine tumours
- (2012) Gabriele Capurso et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Heterogeneity in signaling pathways of gastroenteropancreatic neuroendocrine tumors: a critical look at notch signaling pathway
- (2012) He Wang et al. MODERN PATHOLOGY
- Signaling Pathways as Specific Pharmacologic Targets for Neuroendocrine Tumor Therapy: RET, PI3K, MEK, Growth Factors, and Notch
- (2012) Yvette Carter et al. NEUROENDOCRINOLOGY
- Multiple endocrine neoplasia type 1 in Japan: establishment and analysis of a multicentre database
- (2011) Akihiro Sakurai et al. CLINICAL ENDOCRINOLOGY
- Pancreatic neuroendocrine tumors in patients with tuberous sclerosis complex
- (2011) AM Larson et al. CLINICAL GENETICS
- Pancreatic Endocrine Tumors in Multiple Endocrine Neoplasia Type 1 Syndrome: Review of Literature
- (2011) Francesco Tonelli et al. Endocrine Practice
- Role of Multiple Endocrine Neoplasia Type 1 Mutational Analysis in Clinical Practice
- (2011) Paul Newey et al. Endocrine Practice
- The Epidemiology of Gastroenteropancreatic Neuroendocrine Tumors
- (2011) Ben Lawrence et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- von Hippel–Lindau disease: A clinical and scientific review
- (2011) Eamonn R Maher et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Response, Survival, and Long-Term Toxicity After Therapy With the Radiolabeled Somatostatin Analogue [90Y-DOTA]-TOC in Metastasized Neuroendocrine Cancers
- (2011) Anna Imhof et al. JOURNAL OF CLINICAL ONCOLOGY
- Glucagon cell adenomatosis: A new entity associated with necrolytic migratory erythema and glucagonoma syndrome
- (2011) Agnes I. Otto et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
- (2011) Marianne E Pavel et al. LANCET
- Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
- (2011) Eric Raymond et al. NEW ENGLAND JOURNAL OF MEDICINE
- Everolimus for Advanced Pancreatic Neuroendocrine Tumors
- (2011) James C. Yao et al. NEW ENGLAND JOURNAL OF MEDICINE
- DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
- (2011) Y. Jiao et al. SCIENCE
- Birth incidence and prevalence of tumor-prone syndromes: Estimates from a UK family genetic register service
- (2010) D.G. Evans et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- The Tumor Suppressor Protein Menin Inhibits AKT Activation by Regulating Its Cellular Localization
- (2010) Yan Wang et al. CANCER RESEARCH
- Tumor Suppressor CHK2: Regulator of DNA Damage Response and Mediator of Chromosomal Stability
- (2010) A. Stolz et al. CLINICAL CANCER RESEARCH
- Notch Signaling Proteins: Legitimate Targets for Cancer Therapy
- (2010) Zhiwei Wang et al. CURRENT PROTEIN & PEPTIDE SCIENCE
- Periampullary and Duodenal Neoplasms in Neurofibromatosis Type 1: Two Cases and an Updated 20-Year Review of the Literature Yielding 76 Cases
- (2010) Daniel Relles et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Insulinomatosis
- (2009) Martin Anlauf et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- PH Domain-Only Protein PHLDA3 Is a p53-Regulated Repressor of Akt
- (2009) Tatsuya Kawase et al. CELL
- Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
- (2009) Anja Rinke et al. JOURNAL OF CLINICAL ONCOLOGY
- Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trial
- (2009) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
- Hypoxia-Inducible mir-210 Regulates Normoxic Gene Expression Involved in Tumor Initiation
- (2009) Xin Huang et al. MOLECULAR CELL
- Causes and consequences of microRNA dysregulation in cancer
- (2009) Carlo M. Croce NATURE REVIEWS GENETICS
- Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome
- (2008) C. R. C. Pieterman et al. CLINICAL ENDOCRINOLOGY
- Are neuroendocrine tumours a feature of tuberous sclerosis? A systematic review
- (2008) Dorota Dworakowska et al. ENDOCRINE-RELATED CANCER
- Glucagon Cell Adenomatosis: A Newly Recognized Disease of the Endocrine Pancreas
- (2008) Tobias Henopp et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States
- (2008) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment With the Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate: Toxicity, Efficacy, and Survival
- (2008) Dik J. Kwekkeboom et al. JOURNAL OF CLINICAL ONCOLOGY
- Activity of Sunitinib in Patients With Advanced Neuroendocrine Tumors
- (2008) Matthew H. Kulke et al. JOURNAL OF CLINICAL ONCOLOGY
- Cowden Syndrome: A Critical Review of the Clinical Literature
- (2008) Robert Pilarski Journal of Genetic Counseling
- The many facets of Notch ligands
- (2008) B D'Souza et al. ONCOGENE
- Nesidioblastosis and Hyperplasia of ?? Cells, Microglucagonoma, and Nonfunctioning Islet Cell Tumor of the Pancreas
- (2008) Run Yu et al. PANCREAS
- Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene
- (2007) Manuel C. Lemos et al. HUMAN MUTATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search